We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GATX icon
1676
GATX Corp
GATX
$6.27B
$29K ﹤0.01%
351
-640
-65% -$51.5K
GORO icon
1677
Goldgroup Mining Inc.
GORO
$191M
$29K ﹤0.01%
5,169
-15,159
-75% -$66.2K
GPRO icon
1678
GoPro
GPRO
$126M
$29K ﹤0.01%
6,682
-20,938
-76% -$86.9K
GUNR icon
1679
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.32B
$29K ﹤0.01%
+866
New +$27.6K
ITRI icon
1680
Itron
ITRI
$4.54B
$29K ﹤0.01%
350
+323
+1,196% +$25.4K
LASR icon
1681
nLIGHT
LASR
$3.17B
$29K ﹤0.01%
1,408
-379
-21% -$6.53K
LIN icon
1682
Linde
LIN
$226B
$29K ﹤0.01%
137
-9,613
-99% -$1.94M
LOCO icon
1683
El Pollo Loco
LOCO
$462M
$29K ﹤0.01%
+1,916
New +$26.8K
MRUS
1684
DELISTED
Merus
MRUS
$29K ﹤0.01%
2,049
-643
-24% -$10.3K
NWE icon
1685
NorthWestern Energy
NWE
$4.43B
$29K ﹤0.01%
400
-982
-71% -$70.8K
RNAC icon
1686
Cartesian Therapeutics
RNAC
$268M
$29K ﹤0.01%
405
+403
+20,150% +$19.4K
SAR icon
1687
Saratoga Investment
SAR
$322M
$29K ﹤0.01%
+1,159
New +$29.1K
SVM
1688
Silvercorp Metals
SVM
$2.53B
$29K ﹤0.01%
5,229
-6,329
-55% -$29.4K
TAC icon
1689
TransAlta
TAC
$3.93B
$29K ﹤0.01%
4,161
-3,483
-46% -$22.6K
CASA
1690
DELISTED
Casa Systems, Inc. Common Stock
CASA
$29K ﹤0.01%
+6,996
New +$33.4K
CVET
1691
DELISTED
Covetrus, Inc. Common Stock
CVET
$29K ﹤0.01%
2,163
+1,401
+184% +$17K
GRUB
1692
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$29K ﹤0.01%
300
-976
-76% -$89.4K
APHA
1693
DELISTED
Aphria Inc. Common Shares
APHA
$29K ﹤0.01%
5,482
-641
-10% -$3.15K
BMY.RT
1694
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$29K ﹤0.01%
+9,635
New +$25.1K
MOBL
1695
DELISTED
MobileIron, Inc.
MOBL
$29K ﹤0.01%
5,994
+3,726
+164% +$19.9K
AGCO icon
1696
AGCO
AGCO
$7.2B
$28K ﹤0.01%
362
-447
-55% -$34.3K
BR icon
1697
Broadridge
BR
$19B
$28K ﹤0.01%
226
-3,573
-94% -$437K
CWEN icon
1698
Clearway Energy Class C
CWEN
$6.7B
$28K ﹤0.01%
+1,418
New +$27.4K
DCO icon
1699
Ducommun
DCO
$2.98B
$28K ﹤0.01%
560
-1,513
-73% -$69.7K
DOCU
1700
DocuSign
DOCU
$11.5B
$28K ﹤0.01%
376
+69
+22% +$4.74K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.